Can China’s ‘standard of care’ for COVID-19 be replicated in Europe?

Journal of Medical Ethics 46 (7):451-454 (2020)
  Copy   BIBTEX

Abstract

The Director-General of the WHO has suggested that China’s approach to the COVID-19 crisis could be the standard of care for global epidemics. However, as remarkable as the Chinese strategy might be, it cannot be replicated in other countries and certainly not in Europe. In Europe, there is a distribution of power between the European Union and its member states. In contrast, China’s political power is concentrated in the central government. This enables it to take immediate measures that affect the entire country, such as massive quarantines or closing borders. Moreover, the Chinese legal framework includes restrictions on privacy and other human rights that are unknown in Europe. In addition, China has the technological power to easily impose such restrictions. In most European countries, that would be science fiction. These conditions have enabled China to combat epidemics like no other country can. However, the WHO might have been overoptimistic. The Chinese standard of care for treating COVID-19 also raises problematic issues for human rights, and the real consequences of these actions remain to be seen.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,672

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Chinese Bioethicists Speak Out on Covid‐19, and Others Follow.Susan Gilbert - 2020 - Hastings Center Report 50 (2):inside_front_cover-inside_front_.
European Human Rights Dimension of the Online Access to Cultural Heritage in Times of the COVID-19 Outbreak.Elżbieta Kużelewska & Mariusz Tomaszuk - 2022 - International Journal for the Semiotics of Law - Revue Internationale de Sémiotique Juridique 35 (3):1067-1079.
Lost in ‘Culturation’: medical informed consent in China.Vera Lúcia Raposo - 2019 - Medicine, Health Care and Philosophy 22 (1):17-30.
Ethical challenges in critical care medicine: A chinese perspective.Yali Cong - 1998 - Journal of Medicine and Philosophy 23 (6):581 – 600.
Development and Impact of Chinese Investment in EU.Nguyen Phuoc Hung - 2016 - Creative and Knowledge Society 6 (1):1-14.
Progress and Problems with the Rule of Law in China.Gu Su - 2003 - Contemporary Chinese Thought 34 (3):55-67.

Analytics

Added to PP
2020-05-19

Downloads
33 (#481,697)

6 months
16 (#154,237)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Vera Lúcia Raposo
University of Coimbra

Citations of this work

COVID-19 current controversies.Jennifer Blumenthal-Barby - 2020 - Journal of Medical Ethics 46 (7):419-420.

Add more citations